This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
Drab Near-Term Prospects for Industrial Manufacturing Stocks
by Avisekh Bhattacharjee
The Manufacturing - General Industrial industry is facing coronavirus-related issues, job losses & other problems. Technological advancement in manufacturing processes will likely be a growth driver.
NPO vs. XYL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NPO vs. XYL: Which Stock Is the Better Value Option?
Flowserve (FLS) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Flowserve (FLS) withdraws guidance for 2020, owing to uncertainties in the end-markets on the impacts of the coronavirus outbreak.
Xylem (XYL) Withdraws Guidance Based on Coronavirus Concerns
by Zacks Equity Research
Xylem (XYL) withdraws guidance for the first quarter and 2020, owing to the coronavirus outbreak.
NPO vs. XYL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NPO vs. XYL: Which Stock Is the Better Value Option?
Xylem (XYL) Declines 18% YTD: What's Hurting the Stock?
by Zacks Equity Research
Xylem (XYL), with an 18% decline in shares so far in 2020, faces headwinds from the coronavirus outbreak, softness in commercial and industrial markets, and soft orders.
Xylem (XYL) Down 2.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Reasons Why You Should Avoid IDEX (IEX) Stock for Now
by Zacks Equity Research
IDEX (IEX) is exposed to challenging end markets, unfavorable movements in foreign currencies, and the impacts of variable compensation, tax rate and growth investments.
Here's Why Investors Should Ignore Xylem (XYL) Stock for Now
by Zacks Equity Research
Xylem (XYL) is exposed to challenging end markets, issues related to Coronavirus, soft orders and others. The headwinds are expected to adversely impact its results in the first half of 2020.
Xylem (XYL) Q4 Earnings Estimates Meet, Dividend Rate Rises
by Zacks Equity Research
Xylem's (XYL) Q4 earnings came in line but the same improves year over year on lower interest expenses. The company declares an 8% raise in quarterly dividend rate.
Xylem (XYL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 0.00% and -0.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Xylem's (XYL) Q4 is likely to have gained from the emerging markets business, productivity moves and positive pricing. But soft volumes, end-market weakness and lower margin mix might have ailed.
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Softness in End Markets and Forex Woes to Hurt Xylem (XYL)
by Zacks Equity Research
Xylem's (XYL) 2019 performance will likely suffer from softness in certain end markets and unfavorable movements in foreign currencies. High costs and huge debts are other concerns.
Dull Near-Term Prospects for Industrial Manufacturing Stocks
by Zacks Equity Research
The Manufacturing - General Industrial industry is facing material cost inflation issues. In the long term, technological advancement in manufacturing processes is likely to be a major growth driver.
Xylem (XYL) Meets Q3 Earnings Estimates, Lowers '19 View
by Zacks Equity Research
Xylem's (XYL) third-quarter 2019 earnings meet estimates but rise year over year on solid organic sales and improved margins. The company lowers 2019 earnings projection.
Xylem (XYL) Matches Q3 Earnings Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 0.00% and -2.47%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Xylem's (XYL) third-quarter 2019 results are expected to reflect benefits of strengthening end markets, exposure to emerging markets and product innovation. Cost and forex woes might have been drags.
Xylem (XYL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDEX's Diversified Business and Buyouts Aid Despite Forex Woes
by Zacks Equity Research
IDEX (IEX) gains from a diversified business structure, solid product offerings, acquired assets and shareholder-friendly policies. Geopolitical uncertainties and forex woes are headwinds.
Forget Xylem, Invest in These 4 Industrial Stocks Instead
by Zacks Equity Research
Global uncertainties and tariffs weigh on the Industrial Products sector while technological advancements and e-retailing are positives for the space. We present four stocks that are investment worthy.
Xylem (XYL) Down 2.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem-Planet Water to Extend Tie Up to Solve Water Issues
by Zacks Equity Research
Xylem's (XYL) partnership with Planet Water Foundation will cater to the growing requirements of clean and safe drinking water in disadvantaged communities across remote and rural areas.
The Zacks Analyst Blog Highlights: U.S. Bancorp, Duke Energy, Glaxo, Ross Stores and Xylem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: U.S. Bancorp, Duke Energy, Glaxo, Ross Stores and Xylem
Here's Why it is Worth Holding on to Xylem (XYL) Stock for Now
by Zacks Equity Research
Xylem (XYL) is likely to gain from solid growth prospects in utilities and commercial end markets, shareholder-friendly policies, and long-term tailwinds. Weakness in the European business is dragging.